Buoyed by new data, Santhera preps filing for DMD drug vamoroloneA year ago, Swiss biotech Santhera was slashing staff to cut costs after it abandoned lead Duchenne muscular Share XBuoyed by new data, Santhera preps filing for DMD drug vamorolonehttps://pharmaphorum.com/news/buoyed-by-new-data-santhera-preps-filing-for-dmd-drug-vamorolone/
Living with LHON: Individual struggles, common challengesBeing diagnosed with a rare disease is often a bolt from the blue, and while each person’s journey Share XLiving with LHON: Individual struggles, common challengeshttps://pharmaphorum.com/disease-spotlight/living-with-lhon-individual-struggles-common-challenges/
Living with LHON: Sight loss won’t stop James from seeing the worldWhen he was first told he had LHON, a rare genetic disease that would rob him of his Share XLiving with LHON: Sight loss won’t stop James from seeing the worldhttps://pharmaphorum.com/views-analysis-patients/living-with-lhon-sight-loss-wont-stop-james-from-seeing-the-world/
Living with LHON: Support and friendship fights fear and isolationWhen someone is told they have a rare disease – particularly one like LHON that strips people of Share XLiving with LHON: Support and friendship fights fear and isolationhttps://pharmaphorum.com/disease-spotlight/living-with-lhon-support-and-friendship-fights-fear-and-isolation/
Living with LHON: Adapting to sight loss at 15 years oldWhen faced with a devastating diagnosis, a family has two choices – to give up or make it Share XLiving with LHON: Adapting to sight loss at 15 years oldhttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/living-lhon-sight-loss-santhera/
Diagnostic de la NOHL : sensibiliser le public à la souffrance invisible des patientsMaryse Roger a vécu de près la neuropathie optique héréditaire de Leber (NOHL). Elle a d’abord aidé ses Share XDiagnostic de la NOHL : sensibiliser le public à la souffrance invisible des patientshttps://pharmaphorum.com/spotlight/diagnostic-de-la-nohl-sensibiliser-le-public-a-la-souffrance-invisible-des-patients/
Living with LHON: Adapting to sight loss at 15 years oldWhen faced with a devastating diagnosis, a family has two choices – to give up or make it Share XLiving with LHON: Adapting to sight loss at 15 years oldhttps://pharmaphorum.com/disease-spotlight/living-with-lhon-adapting-to-sight-loss-at-15-years-old/
Drawing strength from growing up with LHONWith a successful music career already in the bag, 24-year-old Fredrik Guzmán Lindemark is now making his mark Share XDrawing strength from growing up with LHONhttps://pharmaphorum.com/disease-spotlight/drawing-strength-from-growing-up-with-lhon/
New support group will help families adapt to LHONPersonal experience of helping her son juggle sight loss and adolescence means Francesca Müeller understands all too well Share XNew support group will help families adapt to LHONhttps://pharmaphorum.com/disease-spotlight/lhon-main/new-support-group-will-help-families-adapt-to-lhon/
